Qiagen is a provider of molecular-diagnostics and sample-preparation tools for labs and clinics. It trades on Frankfurt Stock Exchange (XETRA) under the ticker QIA, in the Life Sciences sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | QIA |
| Exchange | Frankfurt Stock Exchange (XETRA) (QIA) |
| Sector | Life Sciences |
| Headquarters | Venlo, Netherlands |
Bull Case & Risks
Bull Case
- Recurring consumables revenue
- Molecular-diagnostics growth
- Steady, defensive demand
Risks
- Post-COVID testing normalization
- Life-sciences funding cycles
Outlook
Qiagen is a molecular-diagnostics and sample-tech company with sticky consumables and steady demand.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.